Cascade Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Cascade Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-39,455	Closed	-$1.31M	–	184
2017 Q2	$1.31M	Buy	39,455 +3,085	+8%	+$95.5K	1.12%	38
2017 Q1	$1.17M	Buy	36,370 +1,925	+6%	+$65.7K	1.02%	48
2016 Q4	$1.25M	Buy	+34,445	New	+$1.38M	1.06%	46
2016 Q2	$1.65M	Buy	+32,770	New	+$1.74M	1.58%	19

Other funds holding TEVA

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cascade Investment Advisors's TEVA Position: Q3 2017 in Review

Cascade Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 39,455 shares — an estimated $1.31M sold.

Cascade Investment Advisors first reported a position in TEVA in Q2 2016 and held it in 4 quarters. The position peaked at $1.65M in Q2 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

Cascade Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
Cascade Investment Advisors sold 39,455 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $1.31M.
Cascade Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2016 and held it in 4 quarters.
Cascade Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $1.65M in Q2 2016.
537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Cascade Investment Advisors's 13F filing for Q3 2017, filed 12 Oct 2017.